A decreased Level of Shp1 provides an additive survival advantage to the Ph plus Cells of CML Patients and may account for Resistance to Imatinib Treatment
Abstract
Data di Pubblicazione:
2009
Tipologia CRIS:
01.05 Abstract in rivista
Elenco autori:
Quarantelli, Mario; Izzo, Barbara
Link alla scheda completa: